Dan Ruo and the First Affiliated Hospital of Sun Yat-sen University
China’s first third-generation IVF baby turned 20 — what is the connection between DanRuo Hospital and the place where she was born?

The “high-tech baby” who turned 20
China’s first third-generation IVF baby was born at Sun Yat-sen First. What is the connection between DanRuo Hospital’s third-generation IVF programme in Cambodia and the third-generation IVF work at Sun Yat-sen First?
Twenty years ago, on the evening of 23 April 2000, China’s first third-generation IVF baby was born in Guangzhou. The arrival of this healthy girl marked the successful combination of China’s assisted-reproduction technology with modern molecular-biology technology, and the media called her a “high-tech baby”. She has now turned 20 — and has successfully shaken off the “curse” of haemophilia.
Her birth was safeguarded throughout by a renowned Chinese reproductive-medicine expert team — the specialists of the First Affiliated Hospital of Sun Yat-sen University, led by Professor Zhuang Guanglun.
On 13 July 2020, a reporter from Guangzhou Daily’s all-media team learned from the First Affiliated Hospital of Sun Yat-sen University — the birthplace of China’s first third-generation IVF baby — that this hard-won “high-tech baby” has grown up no differently from any other girl, and is now a second-year university student.

Dan Ruo’s connection with Sun Yat-sen First
Both Professor Zhu Wenjie and Dean Peng Wenlin of DanRuo Hospital studied under Professor Zhuang Guanglun at Sun Yat-sen First, and are among the earliest experts in China to begin work on third-generation IVF technology.
Professor Zhu Wenjie
Professor Zhu Wenjie has studied under Professor Zhuang Guanglun at Sun Yat-sen University since 1987, working in female reproductive endocrinology and in the clinical treatment and research of in-vitro fertilisation and embryo transfer (IVF). He has previously served as:
- A member of the first expert panel for assisted-reproduction technology review under the National Health and Family Planning Commission
- A senior postgraduate supervisor at Southern Medical University
- A member of Guangdong Province’s first Reproductive Medicine Branch, and of the first Reproductive Health Group of its Maternal and Child Health Branch
- The first Director of the Reproductive Medicine Centre at Shenzhen Maternity and Child Healthcare Hospital, and its discipline leader
He currently works full-time at DanRuo Hospital in Cambodia.
Dean Peng Wenlin
Dean Peng Wenlin began as a technical backbone of the Reproductive Centre at the First Affiliated Hospital of Sun Yat-sen University in 2000, and subsequently worked on third-generation IVF at Hong Kong Sanatorium & Hospital, in the United States and in Macau. He is among the first batch of embryologists in China to carry out third-generation IVF technology, with close to 20 years’ deep experience and a rich background in embryo biopsy and PGS/PGD.
He also developed and improved a new-generation oocyte (egg) cryopreservation solution that can markedly improve the success rate of egg freezing. In addition, he holds specialised expertise in the in-vitro maturation of immature oocytes (IVM), and successfully completed Hong Kong’s first IVM-assisted pregnancy — reported by the Headline Daily under the headline “Hong Kong artificial-conception success rate rivals that overseas”.
Not every institution can offer third-generation IVF
In mainland China, third-generation IVF technology must be approved step by step by the National Health Commission according to the difficulty of the technique, in the following order:
- Conventional in-vitro fertilisation and embryo transfer (first-generation IVF)
- Intracytoplasmic sperm injection, ICSI (second-generation IVF)
- Preimplantation genetic testing, PGT (third-generation IVF)
Not every institution that is able to perform IVF is permitted to perform third-generation IVF.
Very few institutions in China are approved for third-generation IVF
According to the data published on the official website of the National Health Commission, as of 2006 only four institutions nationwide could carry out third-generation IVF. Even as of 31 December 2019, only 70 institutions were approved, and 12 provinces, autonomous regions or municipalities still had only one — or none at all.


Why do success rates differ so much between institutions?
IVF treatment is a chain of interlocking steps — from ovarian stimulation and egg retrieval, to embryo culture, embryo biopsy and PGS/PGD, and then embryo transfer. Only when every detail is done well can a good final result emerge.
In particular, the steps of in-vitro fertilisation, culture and biopsy all operate on a single egg, a single sperm and a cell mass invisible to the naked eye (the blastocyst). They severely test an embryologist’s “handcraft” and “craftsman spirit”. During one industry discussion of embryo handling, a master embryologist once remarked: “Poor handling is tantamount to murder.” Worth pondering.
Producing a good embryo depends on several factors:
- Egg and sperm quality. Influenced by age and individual physical condition; egg quality is especially important.
- Quality of ovarian stimulation. The stimulation protocol also affects egg quality.
- Embryo-laboratory technique. Many patients who had repeatedly failed IVF elsewhere and then came to DanRuo Hospital once assumed that the low blastocyst rate was caused by their own condition. In practice, that is not necessarily the case.
In short, a good IVF result ultimately rests on accumulated attention to detail and experience.
DanRuo Hospital — third-generation IVF (as reported by the hospital):
First-cycle success rate: 83.2%. Success rate for patients referred to Dan Ruo after failure elsewhere: 66.8%. A good IVF centre lets its results speak for themselves.
Further reading: About DanRuo Hospital | Success rates | In-vitro maturation (IVM) | Our expert team
The success-rate figures above are as reported by DanRuo Hospital for its own third-generation IVF programme; they are historical outcomes and not a guarantee of any individual result. Third-party reproduction, where relevant, is subject to local regulations and hospital confirmation. This page is general information and does not constitute medical advice.









